Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study

Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study

Objectives To investigate the relation between patient characteristics at rheumatoid arthritis (RA) diagnosis and subsequent initiation of treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) or targeted synthetic DMARDs (tsDMARDs).Design A retrospective cohort study.Setting and p...

Full description

Bibliographic Details
Main Authors: Carl Turesson, Giovanni Cagnotto, Mohaned Hameed, Sofia Exarchou, Ulf Bergström, Anna Eberhard, Ankita Sharma, Jon Thorkell Einarsson
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/2/e076131.full

Internet

https://bmjopen.bmj.com/content/14/2/e076131.full

Similar Items